StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the stock.
China Pharma Stock Performance
CPHI stock opened at $0.24 on Friday. The stock has a 50-day moving average price of $0.21 and a two-hundred day moving average price of $0.26. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.21.
China Pharma (NYSE:CPHI – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- 5 Top Rated Dividend Stocks to Consider
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
